Kaloba 21 tablets Dr.Willmar Schwabe

KALOBA

Tablets: 20 mg of dried liquid extract of the roots of Pelargonium sidoides (1: 8 -10) (EPs 7630). The extracting agent is 12% (v / v) ethanol. Drops: 10 g (= 9.75 ml) of solution contain 8.0 g of extract of the roots of Pelargonium sidoides (1: 8 -10) (EPs 7630). The extracting agent is 12% (v / v) ethanol.

Tablets: maltodextrin, microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, precipitated silica, magnesium stearate, hypromellose 5 mPas, macrogol 1500, yellow iron oxide E172, red iron oxide E 172, titanium dioxide E 171, talc, simethicone, methylcellulose, acid sorbic. Drops: 85% glycerol.

Prepare for coughs and colds.

Traditional herbal medicine indicated for the alleviation of the common cold. The use of this traditional herbal medicine, for the indicated therapeutic indications, is based exclusively on the experience of many years of use.

Hypersensitivity 'to the active substance or to any of the excipients. Increased bleeding tendency. Taking drugs that inhibit clotting. Severe liver and kidney disease, as there is insufficient experience in these cases. Pregnancy or breastfeeding. Children under 12 years of age.

Tablets. Adults and adolescents over 12 years of age take 1 tablet 3 times a day (in the morning, at noon and in the evening). The medicine should be taken with some liquid, without being chewed. Drops. Adults and adolescents over 12 years of age take 30 drops 3 times a day. The drops can be taken directly with a spoon or diluted in a little liquid in the morning, at noon and in the evening. Duration of treatment: the maximum duration of therapy is 7 days.

Tablets. This medicinal product does not require any special storage conditions. Drops. Store at a temperature not exceeding 30 degrees C. Note to the patient: After a long period, plant extracts in liquid form may become cloudy; however, this has no effect on the efficacy of the product. Since the solution is a natural product, slight variations in color and taste may occur.

Consult a doctor or a qualified health care practitioner if symptoms persist during use of this medicinal product or if any adverse reactions not reported occur. Consult a doctor if your condition does not improve within a week, if you have a fever that lasts for several days, or if you have tachypnea or hemoptysis (blood in the spit). Tablets: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Drops: this medicinal product contains 12% (v / v) ethanol (alcohol) which corresponds to 180 mg of alcohol for each single dose (30 drops) equivalent to 3.6 ml of beer or 1.5 ml of wine: it can be harmful to alcoholics; to be taken into consideration in adolescents and high-risk groups such as people with liver disease or epilepsy. Avoid concomitant use of other alcohol-containing products.

No information is available regarding possible interactions with other medicinal products. If the patient is already being treated with drugs, it is necessary to take the product after consulting the doctor. Due to the possible influence on coagulation parameters, it cannot be excluded that the product increases the effects of anticoagulant drugs taken concomitantly such as phenprocoumon and warfarin.

Frequencies adverse reactions. Very common: more than 1 in 10 people treated; common: less than 1 in 10 but more than 1 in 100 people treated; uncommon: less than 1 in 100 but more than 1 in 1,000 people treated; rare: less than 1 in 1,000 but more than 1 in 10,000 people treated; very rare: less than 1 in 10,000 people treated, including cases with unknown frequency. Gastrointestinal disorders. Uncommon: stomach pain, heartburn, nausea or diarrhea; rare: mild gingival bleeding. Respiratory, thoracic and mediastinal disorders. Rare: mild nasal bleeding. Skin and subcutaneous tissue disorders / Immune system disorders. Rare: hypersensitivity reactions (type-I reactions with rash, urticaria, itching of the skin and mucous membranes; type-II reactions with formation of antibodies); very rare: severe hypersensitivity reactions' with swelling of the face, dyspnoea and drop in blood pressure. Hepatobiliary disorders. Very rare: impaired liver function; the causal link between this finding and the use of the product has not been demonstrated. Report any suspected adverse reactions via the national reporting system.

Safety during pregnancy and lactation has not been established. As a precautionary measure, due to lack of data, use during pregnancy and lactation is contraindicated.